< LEAST ACCEPTABLE - HARMS - MOST ACCEPTABLE >
Acalabrutinib
Benefit Score: 0
Harms Score: 0
Burden Score: 0
Venetoclax + Obintuzumab
Benefit Score: 0
Harms Score: 0
Burden Score: 0
Acalabrutinib + Obinutuzumab
Benefit Score: 0
Harms Score: 0
Burden Score: 0
Chemotherapy + Rituximab
Benefit Score: 0
Harms Score: 0
Burden Score: 0
Ibrutinib
Benefit Score: 0
Harms Score: 0
Burden Score: 0
Zanubrutinib
Benefit Score: 0
Harms Score: 0
Burden Score: 0
< DESIRABLE - BENEFITS - MOST DESIRABLE >
